Table 1. Sociodemographic data and prostate cancer clinical characteristics and its relation to the MoCA test cut-off scores.

ADT: Androgen deprivation therapy, EAU: European Association of Urology, SD: standard deviation, Sig.: significance, MoCA: Montreal Cognitive Assessment

 P-value > 0.05: Non-significant (NS) ; P-value < 0.05: Significant (S); P-value < 0.01: Highly significant (HS).

*: Chi-square test.

		MoCA after 6 months		Test value	P-value	Sig.
		Normal	Abnormal
		No. = 36	No. =49
		N (%)	N (%)
Level of education	Illiterate	8 (22.2)	14 (28.6)	1.889*	0.596	NS
	Less than five years	7 (19.4)	11 (22.4)
	More than five years	4 (11.1)	2 (4.1)
	College graduate	17 (47.2)	22 (44.9)
Past medical history	Diabetes mellitus	21 (58.3)	30 (61.2)	0.072*	0.788	NS
	Hypertension	22 (61.1)	27 (55.1)	0.307*	0.580	NS
	Ischemic heart disease	16 (44.4)	25 (51.0)	0.359*	0.549	NS
Grade group (according to the Gleason score)	Grade 1	1 (2.8)	0 (0.0)	2.952*	0.399	NS
	Grade 2	9 (25.0)	19 (38.8)
	Grade 3	16 (44.4)	18 (36.7)
	Grade 4	10 (27.8)	12 (24.5)
EAU risk groups	Intermediate risk	12 (46.2)	14 (53.8)	0.228*	0.892	NS
	High-risk	19 (40.4)	28 (59.6)
	Metastatic	5 (41.7)	7 (58.3)